NASDAQ:DXCM
Dexcom Inc.
Dexcom Inc.'s revenue grew 15.6% in fiscal 2025 to $4.7B while operating margin rose to 19.6%, its highest in 10 years. Free cash flow was $1.1B, 23.1% of revenue, and the diluted share count fell 1.7%.Summary generated from Dexcom Inc.'s SEC filings. Latest annual report filed Feb 12, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$4.7B
Revenue growth+15.6%
Revenue, 5-yr CAGR+19.3%
Gross margin60.1%
Operating margin19.6%
Net margin17.9%
ROICn/a
Return on equity34.5%
Debt / equityn/a
Free cash flow$1.1B
FCF margin23.1%
Share count change−1.7%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2,449 | 2,910 | 3,622 | 4,033 | 4,662 |
| Operating income | 266 | 391 | 598 | 600 | 912 |
| Net income | 217 | 341 | 542 | 576 | 836 |
| Free cash flow | 53 | 305 | 512 | 631 | 1,077 |
Recent filings
- 4Insider transaction report
Sep 30, 2026 - 4Insider transaction report
Sep 16, 2026 - 8-KDirector or officer change
Sep 14, 2026 - 8-KDirector or officer change
Sep 10, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Jul 30, 2026 - 8-KResults of operations and financial condition
Jul 30, 2026 - 8-KResults of a shareholder vote
May 28, 2026 - 8-KRegulation FD disclosure
May 15, 2026